Antelope Valley Hospital and Kentucky-based Kindred Healthcare have entered into a joint venture to build and operate a new specialty hospital in Lancaster.
The number of available intensive care unit beds has plummeted in Los Angeles County, with only 92 ICU beds available countywide.
The U.S. Food and Drug Administration has approved the first at-home COVID-19 test, developed by a biotech company with ties to the Valley region.
Nurses at two hospitals in the Valley region have called a 10-day strike from Dec. 24 to Jan. 3 to protest unfair labor practices.
Westlake Village BioPartners has announced two new funds totaling $500 million to invest in life science startups and construct lab facilities for them.
Atara Biotherapeutics and German pharmaceutical giant Bayer have entered into a strategic collaboration to develop therapies for solid tumors.
MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.
Amgen Inc. and Texas-based health care supply company McKesson Corp. have announced a multi-year, strategic partnership to help bridge gaps in cancer care.
Amgen Inc.’s drug Otezla will appear in a COVID-19 clinical trial, as part of testing efforts by the COVID R&D Alliance consortium of companies.
Amgen Inc. has terminated its collaboration with Bay area startup Cytokinetics.
MannKind Corp. in Westlake Village has received its final $12.5 million milestone payment from United Therapeutics.
California Lutheran University in Thousand Oaks will offer a minor in public health starting in January
Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat for the fourth financial quarter.
Ventura County has dropped to the most restrictive COVID-19 reopening framework tier.
Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.